Clearstead Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.3M	Sell	3,938 -28	-0.7%	-$9.53K	0.21%	63
2025 Q4	$1.58M	Sell	3,966 -28	-0.7%	-$12.4K	0.25%	59
2025 Q3	$1.82M	Sell	3,994 -286	-7%	-$116K	0.31%	53
2025 Q2	$1.4M	Buy	4,280 +288	+7%	+$79.7K	0.26%	59
2025 Q1	$1.08M	Buy	3,992 +11	+0.3%	+$2.83K	0.24%	65
2024 Q4	$937K	Hold	3,981	–	–	0.2%	67
2024 Q3	$1.09M	Hold	3,981	–	–	0.26%	58
2024 Q2	$967K	Hold	3,981	–	–	0.24%	58
2024 Q1	$595K	Hold	3,981	–	–	0.16%	73
2023 Q4	$762K	Hold	3,981	–	–	0.21%	71
2023 Q3	$705K	Hold	3,981	–	–	0.23%	68
2023 Q2	$766K	Hold	3,981	–	–	0.25%	66
2023 Q1	$797K	Hold	3,981	–	–	0.25%	67
2022 Q4	$946K	Hold	3,981	–	–	0.32%	56
2022 Q3	$796K	Buy	3,981 +3,000	+306%	+$572K	0.28%	60
2022 Q2	$143K	Hold	981	–	–	0.11%	88
2022 Q1	$160K	Sell	981 -142	-13%	-$21.6K	0.1%	94
2021 Q4	$190K	Hold	1,123	–	–	0.11%	91
2021 Q3	$212K	Buy	+1,123	New	+$211K	0.13%	87